Bentham Science Logo

Editor's Choice

PARP Inhibitors in Ovarian Cancer

, 2018; 13(4): 392 - 410

Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Sofia Genta, Massimo Aglietta, Anna Sapino and Giorgio Valabrega*


DOI: 10.2174/1574892813666180305165256


Oral Submucous Fibrosis as an Overhealing Wound: Implications in Malignant Transformation

, 2018; 13(3): 272 - 291

Mohit Sharma, Smitha S. Shetty and Raghu Radhakrishnan*


DOI: 10.2174/1574892813666180227103147



Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy

, 2018; 13(1): 2 - 17

Sandra Iurescia*, Daniela Fioretti and Monica Rinaldi*


DOI: 10.2174/1574892812666171030163804



Pharmacological Inhibitors of NAD Biosynthesis as Potential An ticancer Agents

, 2017; 12(3): 190 - 207

Stephanie Lucas, Claire Soave, Ghazal Nabil, Zainab Sabry Othman Ahmed, Guohua Chen, Hossny Awad El-Banna, Q. Ping Dou* and Jian Wang*


DOI: 10.2174/1574892812666170619125503



Marine Derived Anticancer Drugs Targeting Microtubule

, 2017; 12(2): 102 - 127

Oindrila De and Biswa P. Chatterji*


DOI: 10.2174/1574892812666170109141003



Kinase Inhibitor Indole Derivatives as Anticancer Agents: A Patent Review

, 2017; 12(1): 55 - 72

Anuj K. Rathi, Riyaz Syed, Vijay Singh, Han-Seung Shin and Rahul V. Patel


DOI: 10.2174/1574892811666161003112119



Medicinal Chemistry Insights into Novel HDAC Inhibitors: An Updated Patent Review (2012-2016)

, 2017; 12(1): 16 - 34

Peng Zhan, Xueshun Wang, Xinyong Liu and Takayoshi Suzuki


DOI: 10.2174/1574892811666161101102842



HOXB7 and Hsa-miR-222 as the Potential Therapeutic Candidates for Metastatic Colorectal Cancer

, 2016; 11(4): 434 - 443

Maryam Iman, Seyede Samaneh Mostafavi, Seyed Shahriar Arab, Sadegh Azimzadeh and Mansour Poorebrahim


DOI: 10.2174/1574892811999160628114857



Liposomal Irinotecan in the Treatment of Refractory Pancreatic Cancer

, 2016; 11(4): 376 - 383

Harold Bien, Gerardo G. Mackenzie and Minsig Choi


DOI: 10.2174/1574892811666160729094415



Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery*

, 2016; 11(3): 254 - 266

Zsuzsanna Suba


DOI: 10.2174/1574892811666160415160211



Review of PI3K/mTOR Inhibitors Entering Clinical Trials to Treat Triple Negative Breast Cancers

, 2016; 11(3): 283 - 296

Amélie Fouqué, Mickael Jean, Pierre van de Weghe and Patrick Legembre


DOI: 10.2174/1574892811666160519113731



Improved Anti-Tumor Activity of Novel Highly Bioactive Liposome-Bound TRAIL in Breast Cancer Cells

, 2016; 11(2): 197 - 214

Diego De Miguel, Ana Gallego-Lleyda, José M. Ayuso, Aleksandra Pawlak, Blanca Conde, Ignacio Ochoa, Luis J. Fernández, Alberto Anel and Luis Martinez-Lostao


DOI: 10.2174/1574892811666160229121544



Isoliquiritigenin Inhibits Proliferation and Induces Apoptosis via Alleviating Hypoxia and Reducing Glycolysis in Mouse Melanoma B16F10 Cells

, 2016; 11(2): 215 - 227

Yanming Wang, Jun Ma, Xinyan Yan, Xiaoyu Chen, Lingling Si, Ying Liu, Jichun Han, Wenjin Hao and Qiusheng Zheng


DOI: 10.2174/1573406412666160307151904



Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far

, 2016; 11(1): 67 - 97

Devivasha Bordoloi, Nand K. Roy, Javadi Monisha, Ganesan Padmavathi and Ajaikumar B. Kunnumakkara


DOI: 10.2174/1574892810666151020101706


Saffron-Based Crocin Prevents Early Lesions of Liver Cancer: In vivo, In vitro and Network Analyses

, 2016; 11(1): 121 - 133

Amr Amin, Alaaeldin A. Hamza, Sayel Daoud, Kamal Khazanehdari, Ala’a Al Hrout, Badriya Baig, Amphun Chaiboonchoe, Thomas E. Adrian, Nazar Zaki and Kourosh Salehi-Ashtiani


DOI: 10.2174/1574892810666151102110248


Perspectives in Engineered Mesenchymal Stem/Stromal Cells Based Anti- Cancer Drug Delivery Systems

, 2016; 11(1): 98 - 111

Darinka Gjorgieva Ackova, Tatjana Kanjevac, Lia Rimondini and Darko Bosnakovski


DOI: 10.2174/1574892811666151111142721



FOXM1 and its Oncogenic Signaling in Gastric Cancer

, 2015; 10(3): 270 - 279

Hanying Wang and Chen Huang


DOI: 10.2174/1574892810666150617112421


pH Gradient Reversal: An Emerging Hallmark of Cancers

, 2015; 10(3): 244 - 258

Mohit Sharma, Madhusudan Astekar, Sonal Soi, Bhari S. Manjunatha, Devi C. Shetty and Raghu Radhakrishnan


DOI: 10.2174/1574892810666150708110608


Cabozantinib in Thyroid Cancer

, 2015; 10(3): 259 - 269

Poupak Fallahi, Silvia M. Ferrari, Flavia Di Bari, Gabriele Materazzi, Salvatore Benvenga, Paolo Miccoli and Alessandro Antonelli


DOI: 10.2174/1574892810666150708110816



HDAC Inhibitors as Novel Anti-Cancer Therapeutics

, 2015; 10(2): 145 - 162

Cristabelle De Souza and Biswa P. Chatterji


DOI: 10.2174/1574892810666150317144511



Immune Checkpoint Inhibition: Therapeutic Implications in Epithelial Ovarian Cancer

, 2015; 10(2): 133 - 144

Teresa C. Longoria and Ramez N. Eskander


DOI: 10.2174/1574892810666150504121000


Alteronol Induces Differentiation of Melanoma B16-F0 Cells

, 2015; 10(1): 116 - 127

Caixia Wang, Bo Zhang, Na Chen, Liangliang Liu, Jinglei Liu, Qi Wang, Zhenhua Wang, Xiling Sun and Qiusheng Zheng


DOI: 10.2174/1574892809666140923125521


Cancer Stem Cells: The ‘Achilles Heel’ of Chemo-Resistant Tumors

, 2015; 10(1): 2 - 22

In-Sun Hong, Hwa-Yong Lee and Jeong-Seok Nam


DOI: 10.2174/1574892809666141129172658


Targeting Hormonal Signaling Pathways in Castration Resistant Prostate Cancer

, 2014; 9(3): 267 - 285

Marilena Manea, Marina Montagnani Marelli, Roberta M. Moretti, Roberto Maggi, Monica Marzagalli and Patrizia Limonta


DOI: 10.2174/1574892809666140520113953


Cell Surface Nucleolin as a Target for Anti-Cancer Therapies

, 2014; 9(2): 137 - 152

Marina Koutsioumpa and Evangelia Papadimitriou


DOI: 10.2174/1574892808666131119095953



Webmaster Contact: info@benthamscience.net
Copyright © 2019 Bentham Science